ReviewJournal of clinical medicine2026

Circulating Tumor DNA as a Biomarker of Treatment Response and Minimal Residual Disease in Diffuse Large B-Cell Lymphoma: A Literature Review.

Polina Chernova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.